The strategic investments expanding CDMO capabilities for HPAPIs and ADCs
Demand for HPAPIs and ADCs is accelerating, prompting CDMOs to invest in integration, containment, and advanced technologies to strengthen supply chains and deliver scalable, high-value manufacturing solutions for oncology innovation.
